EN
HI
Balaxi Pharmaceuticals Chart
Balaxi Pharmaceuticals Share Key Metrics
Volume
3.41 L
Market Cap
116.60 CR
LTQ@LTP
200@21.12
ATP
20.57
Var Margin
25.53 %
Circuit Range
15.04-22.56
Delivery %
73.75 %
Value
70.08 L
ASM/GSM
No
Market Lot
1
Summary
At 2 Apr, 2026 | 15:31, Balaxi Pharmaceuticals share price stands at ₹21.12, showing a 2.32% 12.34 for the day. The stock’s intraday movement has stayed between ₹18.02 and ₹21.98, while on a 52-week basis it has fluctuated from ₹15.20 to ₹73.70.
In terms of trading activity, Balaxi Pharmaceuticals has recorded a volume of 340710 shares, with a market capitalisation of ₹55207500. The stock’s Average Traded Price (ATP) stands at ₹2057, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 200,2112. The stock operates within a circuit range of ₹15.04-22.56, with a Value of ₹70.08 L. The Delivery Percentage for the day is 73.75%. Additionally, Balaxi Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.
Balaxi Pharmaceuticals Fundamentals
View MoreP/E Ratio
10.99
P/B Ratio
0.44
Div. Yield
0
Sector P/E
37.04
Sector P/B
1.91
Sec. Div. Yield
82.37
Balaxi Pharmaceuticals Resistance and Support
Pivot 17.88
Resistance
First Resistance
19.73
Second Resistance
20.65
Third Resistance
22.5
Support
First Support
16.96
Second Support
15.11
Third Support
14.19
Balaxi Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-01-28 | Quarterly Results & Others |
| 2025-11-11 | Quarterly Results & Others |
| 2025-08-05 | Quarterly Results & Others |
| 2025-05-30 | Audited Results & Others |
| 2025-02-10 | Quarterly Results & Others |
Balaxi Pharmaceuticals News
BALAXI PHARMACEUTICALS LIMITED (BALAXI)
Balaxi Pharmaceuticals' board will meet to consider the audited financial results for Q4 FY26. The specific date of this meeting will be announced later.
Mar 27 2026 01:03:00
BALAXI PHARMACEUTICALS LIMITED (BALAXI)
Balaxi Pharmaceuticals appointed Mr. Aman Purohit as Company Secretary, effective March 25, 2026. He brings 6 years of experience in secretarial compliance, including major assignments like mergers and acquisitions.
Mar 25 2026 19:03:00
Read More
About Balaxi Pharmaceuticals
NSE : 11309
BSE : 0
ISIN : INE618N01022
Balaxi Pharmaceuticals Management
| Name | Position |
|---|---|
| Mr. Ashish Maheshwari | Managing Director |
| Mrs. Minoshi Maheshwari | Non Executive Director |
Balaxi Pharmaceuticals Similar Stocks
Balaxi Pharmaceuticals FAQs
The Buying Price of Balaxi Pharmaceuticals share is 21.12 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Balaxi Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Balaxi Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Balaxi Pharmaceuticals shares is 10.99. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Balaxi Pharmaceuticals shares is 0.44. Useful to assess the stock's value relative to its book value.
To assess Balaxi Pharmaceuticals’s valuation compare Sector P/E, P/B which are 37.04 & 1.91 with sector averages, along with growth rates and financial metrics.
The Market Cap of Balaxi Pharmaceuticals is 116.60 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Balaxi Pharmaceuticals share price is 73.70 & 15.20. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Balaxi Pharmaceuticals belongs to the Miscellaneous sector.
